V

VolitionRX Limited
D

VNRX

0.80280
USD
0.00
(0.35%)
Market Closed
Volume
757
EPS
-1
Div Yield
-
P/E
-2
Market Cap
74,391,311
OverviewSignalsIdeasNews
Related Instruments
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    V
    VNRX
    -0.05360
    (-7.31%)
    0.68000 USD
    V
    VRAY
    -0.07500
    (-2.12%)
    3.46000 USD
    V
    VRNA
    0.270
    (0.76%)
    35.660 USD
    V
    VTVT
    1.350
    (8.46%)
    17.310 USD
    V
    VYNE
    -0.15000
    (-5.28%)
    2.69000 USD
    Z
    ZYNE
    0
    (0%)
    0.000000 USD
    More
News

Title: VolitionRX Limited

Sector: Healthcare
Industry: Diagnostics & Research
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.